Skip to content
HowShorted

Cidara Therapeutics, Inc. short interest in 2024

In 2024, Cidara Therapeutics, Inc.'s disclosed short interest ran from 0.69% of shares outstanding on 12 Jan 2024 to 1.09% on 31 Dec 2024, a change of +0.40 percentage points. The year's high was 1.41% on 15 Aug 2024 and its low 0.18% on 15 Apr 2024, averaging 0.72% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 5.43 days on 15 Aug 2024. Full history: Cidara Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025

Aggregate net short position time series for Cidara Therapeutics, Inc. in 2024

2024 in figures

Start of year
0.69% (12 Jan 2024)
End of year
1.09% (31 Dec 2024)
Change
+0.40 pp
High
1.41% (15 Aug 2024)
Low
0.18% (15 Apr 2024)
Average
0.72%
Highest days to cover
5.43 (15 Aug 2024)
SEC filings marked
8

Every report in 2024

Cidara Therapeutics, Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 20240.69%1.43
31 Jan 20240.66%1.00
15 Feb 20240.51%1.06
29 Feb 20240.24%1.00
15 Mar 20240.20%1.00
28 Mar 20240.22%1.00
15 Apr 20240.18%1.00
15 Aug 20241.41%5.4310-K filed, results (8-K), 10-Q filed, results (8-K), 10-Q filed, results (8-K)
30 Aug 20241.08%3.21
13 Sep 20240.93%3.89
30 Sep 20241.19%4.31
15 Oct 20240.95%4.55
31 Oct 20240.92%2.77
15 Nov 20240.71%2.4010-Q filed, results (8-K)
29 Nov 20240.75%1.00
13 Dec 20240.51%1.00
31 Dec 20241.09%1.00

See also: Cidara Therapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.